The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to healthy tissue from patient samples.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

Cancers Symposium, and the updates were full of hope for people with advanced prostate cancer. CURE highlights two studies ...

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...